documents: FDA-2020-P-1617-0005

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2020-P-1617-0005 FDA FDA-2020-P-1617 Determination That BACTROBAN (Mupirocin) Nasal Ointment, 2%, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness Notice Determinations 2025-12-12T05:00:00Z 2025 12 2025-12-12T05:00:00Z   2025-12-12T19:43:45Z 2025-22682 0 0 09000064b90c85b0

Links from other tables